DECIPHERA PHARMACEUTICALS IN

CUSIP: 24344T101 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 27,220 Value ($000) $428 Avg Close Range
Q4 2023
Shares 27,220 Value ($000) $439 Avg Close Range
Q3 2023
Shares 27,220 Value ($000) $346 Avg Close Range
Q2 2023
Shares 27,220 Value ($000) $383 Avg Close Range
Q1 2023
Shares 27,220 Value ($000) $421 Avg Close Range
Q4 2022
Shares 23,468 Value ($000) $385 Avg Close Range
Q3 2022
Shares 23,468 Value ($000) $434 Avg Close Range
Q2 2022
Shares 23,468 Value ($000) $309 Avg Close Range
Q1 2022
Shares 23,468 Value ($000) $218 Avg Close Range
Q4 2021
Shares 15,140 Value ($000) $148 Avg Close Range
Q3 2021
Shares 15,140 Value ($000) $514 Avg Close Range
Q2 2021
Shares 15,140 Value ($000) $554 Avg Close Range
Q1 2021
Shares 15,140 Value ($000) $679 Avg Close Range
Q4 2020
Shares 15,140 Value ($000) $864 Avg Close Range
Q3 2020
Shares 16,598 Value ($000) $851 Avg Close Range
Q2 2020
Shares 16,598 Value ($000) $991 Avg Close Range
Q1 2020
Shares 8,722 Value ($000) $359 Avg Close Range
Q4 2019
Shares 8,722 Value ($000) $543 Avg Close Range
Q3 2019
Shares 7,563 Value ($000) $257 Avg Close Range
Q2 2019
Shares 7,563 Value ($000) $171 Avg Close Range
Q3 2018
Shares 3,916 Value ($000) $152 Avg Close Range